Почему вакцина против ВИЧ не сработала для всех?
Рossible Clues Found to Why HIV Vaccine Showed Modest Protection
"ScienceDaily (Apr. 4, 2012) - Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were recently published online in the New England Journal of Medicine. Scientists have found that among adults who received the experimental HIV vaccine during the landmark RV144 clinical trial, those who produced relatively high levels of a specific antibody after vaccination were less likely to get infected with the virus than those who did not. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, co-funded the research."
У вакцинированных, у которых титры антител были более высокими, то есть кто выдал бОльший иммунный ответ, вероятность инфицирования ВИЧ была ниже (сосбтвенно, зачем тогда было их прививать?)
http://www.sciencedaily.com/releases/2012/04/120404210003.htm
"ScienceDaily (Apr. 4, 2012) - Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were recently published online in the New England Journal of Medicine. Scientists have found that among adults who received the experimental HIV vaccine during the landmark RV144 clinical trial, those who produced relatively high levels of a specific antibody after vaccination were less likely to get infected with the virus than those who did not. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, co-funded the research."
У вакцинированных, у которых титры антител были более высокими, то есть кто выдал бОльший иммунный ответ, вероятность инфицирования ВИЧ была ниже (сосбтвенно, зачем тогда было их прививать?)
http://www.sciencedaily.com/releases/2012/04/120404210003.htm